Showing results (2601-2610 of 6,433) with videos related to

Sort By:
Pageof 644
World Journal of Urology|December 17, 2018
Prognostic models for predicting overall survival in metastatic castration-resistant prostate cancer: a systematic reviewM Pinart, F Kunath, V Lieb, et al.
World Journal of Urology|December 6, 2019
Relation of ADRB3, GEF, ROCK2 gene polymorphisms to clinical findings in overactive bladderElif Fırat, Zafer Aybek, Şakir Akgün, et al.
World Journal of Urology|December 13, 2019
The evaluation of early predictive factors for urosepsis in patients with negative preoperative urine culture following mini-percutaneous nephrolithotomyZewu Zhu, Yu Cui, Huimin Zeng, et al.
World Journal of Urology|February 14, 2019
Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional studyAhmet M Aydin, Nirmish Singla, Vandana Panwar, et al.
World Journal of Urology|December 4, 2019
High-resolution imaging reveals microbial biofilms on patient urinary catheters despite antibiotic administrationJennifer N Walker, Ana L Flores-Mireles, Aaron J L Lynch, et al.
World Journal of Urology|December 4, 2019
Serum sphingosine-1-phosphate levels in bladder pain syndrome/interstitial cystitis patients: could it help in diagnosis?Tariq Asi, Ahmet Asci, Mesut Altan, et al.
World Journal of Urology|October 30, 2019
Laser fibre, rather than the stone, may harm the scope: retrospective monocentric analysis of 26 pre- and intraoperative factors of flexible ureteroscope (fURS) damageTomasz Ozimek, Jens Cordes, Nils Gilbert, et al.
World Journal of Urology|December 2, 2020
Treatment of post-prostatectomy urinary incontinence and erectile dysfunction: there is insufficient utilisation of care in German cancer survivorsMartin Baunacke, Maria-Luisa Schmidt, Christer Groeben, et al.
World Journal of Urology|February 12, 2018
Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinomaM Hegemann, N Kroeger, A Stenzl, et al.
World Journal of Urology|March 20, 2020
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trialPeter Albers, Thomas Wiegel, Heinz Schmidberger, et al.
Pageof 644